Neal J. Meropol, MD is a medical oncologist, clinical investigator and outcomes researcher who serves as Vice President of Research Oncology at Flatiron Health. In this role, he provides scientific and clinical leadership in leveraging Flatiron’s technology platforms to close the gap between research and clinical care. Dr. Meropol is the current chair of the NCI Director's Clinical Trials and Translational Research Advisory Committee (CTAC), and previously served as chair of the National Cancer Institute Gastrointestinal Cancer Steering Committee. Dr. Meropol completed a four-year term as an elected member of the American Society of Clinical Oncology (ASCO) Board of Directors, and currently serves on the ASCO Research Committee.